Dyadic International (DYAI) Shares Issued (2018 - 2026)
Dyadic International (DYAI) posted Shares Issued of $5.6 million for Q1 2026, up 5.08% sequentially from $5.4 million in Q4 2025, and down 10.61% YoY from $6.3 million in Q1 2025.
Dyadic International (DYAI) Shares Issued (2018 - 2026) Analysis & Trends
Dyadic International has reported Shares Issued for 9 years, with the latest figure at $5.6 million in Q1 2026.
- Quarterly Shares Issued fell 10.61% year-over-year to $5.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.6 million (down 10.61% YoY) and the FY2025 annual result came in at $5.4 million, down 7.36% from the prior year.
- Shares Issued improved to $5.6 million in Q1 2026 per DYAI's latest filing, from $5.4 million in the prior quarter.
- Over five years, Shares Issued peaked at $6.3 million in Q1 2025 and troughed at $3.9 million in Q3 2022.
- A 5-year average of $5.2 million and a median of $5.5 million in 2023 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2022 and 2023: Shares Issued fell 19.65% in 2022, then jumped 41.78% in 2023.
- Over 5 years, Shares Issued stood at $5.0 million in 2022, then gained by 8.71% to $5.5 million in 2023, then increased by 5.84% to $5.8 million in 2024, then decreased by 7.36% to $5.4 million in 2025, then climbed by 5.08% to $5.6 million in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $5.6 million, $5.4 million, and $5.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Dyadic International | 19.98 Mn | 19.98 Mn | - | 5.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.64 Mn |
| Mar 31, 2026 | 5.64 Mn |
| Dec 31, 2025 | 5.36 Mn |
| Dec 31, 2025 | 5.36 Mn |
| Sep 30, 2025 | 5.93 Mn |
| Sep 30, 2025 | 5.93 Mn |
| Jun 30, 2025 | 6.00 Mn |
| Jun 30, 2025 | 6.00 Mn |
| Mar 31, 2025 | 6.30 Mn |
| Mar 31, 2025 | 6.30 Mn |
| Dec 31, 2024 | 5.79 Mn |
| Dec 31, 2024 | 5.79 Mn |
| Sep 30, 2024 | 5.85 Mn |
| Sep 30, 2024 | 5.85 Mn |
| Jun 30, 2024 | 4.43 Mn |
| Jun 30, 2024 | 4.43 Mn |
| Mar 31, 2024 | 4.49 Mn |
| Mar 31, 2024 | 4.49 Mn |
| Dec 31, 2023 | 5.47 Mn |
| Dec 31, 2023 | 5.47 Mn |